Literature DB >> 18219807

Global Advisory Committee on Vaccine Safety, 12-13 December 2007.

.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18219807

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  8 in total

Review 1.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Updated Statement on the use of Rotavirus Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-07-16

Review 3.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

4.  An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.

Authors:  Susan L Hills; Sann Chan Soeung; Svay Sarath; Chheng Morn; Cheam Dara; Marc Fischer; Michael C Thigpen
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

5.  Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors:  Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

6.  Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.

Authors:  Pushpa Ranjan Wijesinghe; M R Nihal Abeysinghe; Sutee Yoksan; Yafu Yao; Benli Zhou; Lei Zhang; Jessica A Fleming; Anthony A Marfin; John C Victor
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

7.  Past, present, and future of Japanese encephalitis.

Authors:  Tobias E Erlanger; Svenja Weiss; Jennifer Keiser; Jürg Utzinger; Karin Wiedenmayer
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

8.  Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data.

Authors:  Giulia Bonaldo; Roberta Noseda; Alessandro Ceschi; Alberto Vaccheri; Domenico Motola
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.